表紙
市場調查報告書

抗菌藥的全球市場 - 產業洞察,市場趨勢,預測,市場機會分析 2016年∼2024年

Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

出版商 Coherent Market Insights 商品編碼 798090
出版日期 內容資訊 英文 156 Pages
商品交期: 2-3個工作天內
價格
Back to Top
抗菌藥的全球市場 - 產業洞察,市場趨勢,預測,市場機會分析 2016年∼2024年 Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日期: 2019年02月26日內容資訊: 英文 156 Pages
簡介

抗菌藥,用於由於氣候的變化,及發展中國家的衛生狀態惡劣等要素而引起的細菌性感染疾病的治療或預防。抗菌藥相關的主要課題,是細菌持有抗菌藥抗性。為了對應抗生素抗藥性菌的課題,針對新的抗菌藥的開發進行重要的研究。

本報告提供全球抗菌藥市場調查,市場概要,各醫藥品分類、給藥途徑、流通管道、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各醫藥品分類
    • 市場片段:各給藥途徑
    • 市場片段:各流通管道
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 償付方案
  • 流行病學
  • PESTEL分析
  • 法規方案
  • 新產品的銷售
  • 聯盟、協定
  • 市場趨勢

第4章 全球抗菌藥市場:各醫藥品分類

  • 簡介
  • β-內醯胺
  • 奎諾酮類抗生素(Quinolones)
  • 大環內酯類
  • 四環黴素
  • Aminoglycosides
  • 磺胺類藥物
  • 氯黴素
  • 其他

第5章 全球抗菌藥市場:各給藥途徑

  • 簡介
  • 口服
  • 局部
  • 非口服
  • 其他

第6章 全球抗菌藥市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球抗菌藥市場:各地區

  • 簡介
  • 北美
  • 中南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Novartis AG
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.
  • 分析師的意見

第9章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.

However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business

Key features of the study:

  • This report provides in-depth analysis of the antibacterial drugs market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global antibacterial drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Bayer AG, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the antibacterial drugs market

Detailed Segmentation

  • Global Antibacterial Drugs Market, By Drug class:
    • Beta lactams
    • Quinolones Macrolides
    • Tetracycline
    • Aminoglycoside
    • Sulfonamide
    • Phenicols
    • Others
  • Global Antibacterial Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
    • Others
  • Global Antibacterial Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antibacterial Drugs Market, By Geography:
    • North America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Novartis AG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Beta lactams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Quinolones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Macrolides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Tetracyclines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Aminoglycosides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Sulphonamides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Phenicols
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

5. Global Antibacterial Drugs Market, By Route of Administration, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

6. Global Antibacterial drugs Market, By Distribution Channel, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

7. Global Antibacterial Drugs Market, By Region, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Allergan
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline Plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi SA
    • Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top